VanEck Associates’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,977
| Closed | -$126K | – | 1430 |
|
|
2024
Q1 | $126K | Buy |
2,977
+133
| +5% | +$5.63K | ﹤0.01% | 1223 |
|
|
2023
Q4 | $119K | Sell |
2,844
-90
| -3% | -$3.77K | ﹤0.01% | 1219 |
|
|
2023
Q3 | $111K | Buy |
2,934
+187
| +7% | +$7.08K | ﹤0.01% | 1222 |
|
|
2023
Q2 | $104K | Sell |
2,747
-19
| -0.7% | -$719 | ﹤0.01% | 1235 |
|
|
2023
Q1 | $67K | Sell |
2,766
-39
| -1% | -$945 | ﹤0.01% | 1287 |
|
|
2022
Q4 | $81K | Sell |
2,805
-10
| -0.4% | -$289 | ﹤0.01% | 1281 |
|
|
2022
Q3 | $84K | Buy |
2,815
+9
| +0.3% | +$269 | ﹤0.01% | 1205 |
|
|
2022
Q2 | $101K | Sell |
2,806
-132
| -4% | -$4.75K | ﹤0.01% | 1221 |
|
|
2022
Q1 | $127K | Buy |
2,938
+16
| +0.5% | +$692 | ﹤0.01% | 1190 |
|
|
2021
Q4 | $146K | Sell |
2,922
-211
| -7% | -$10.5K | ﹤0.01% | 1172 |
|
|
2021
Q3 | $199K | Sell |
3,133
-227
| -7% | -$14.4K | ﹤0.01% | 1034 |
|
|
2021
Q2 | $242K | Buy |
3,360
+28
| +0.8% | +$2.02K | ﹤0.01% | 982 |
|
|
2021
Q1 | $246K | Buy |
+3,332
| New | +$246K | ﹤0.01% | 923 |
|
|
2014
Q3 | – | Sell |
-4,270
| Closed | -$599K | – | 735 |
|
|
2014
Q2 | $599K | Sell |
4,270
-17
| -0.4% | -$2.39K | ﹤0.01% | 463 |
|
|
2014
Q1 | $476K | Buy |
4,287
+890
| +26% | +$98.8K | ﹤0.01% | 473 |
|
|
2013
Q4 | $336K | Buy |
+3,397
| New | +$336K | ﹤0.01% | 507 |
|